RXST
RXST
NASDAQ · Health Care

Rxsight Inc

$5.95
-0.05 (-0.83%)
Financial Highlights (FY 2026)
Revenue
140.01M
Net Income
-40,543,593
Gross Margin
76.6%
Profit Margin
-29.0%
Rev Growth
+40.0%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.6% 76.6% 56.0% 56.0%
Operating Margin -35.8% -32.3% 19.2% 20.8%
Profit Margin -29.0% -27.5% 16.8% 12.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 140.01M 100.01M 45.49M 50.58M
Gross Profit 107.25M 76.60M 25.48M 28.33M
Operating Income -50,178,822 -32,257,814 8.73M 10.51M
Net Income -40,543,593 -26,063,738 7.66M 6.55M
Gross Margin 76.6% 76.6% 56.0% 56.0%
Operating Margin -35.8% -32.3% 19.2% 20.8%
Profit Margin -29.0% -27.5% 16.8% 12.9%
Rev Growth +40.0% +40.0% +1.5% +13.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 34.9K 34.9K 28.42M 28.12M
Total Equity 116.49M 116.49M 288.95M 248.82M
D/E Ratio 0.00 0.00 0.10 0.11
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -50,138,300 -34,022,417 11.61M 13.24M
Free Cash Flow 5.18M 4.95M